Evidence map›Paper›PMID 40672052›Full record

ArticleThe Lancet regional health. Europe2025

External exposome and incident asthma across the life course in 14 European cohorts: a prospective analysis within the EXPANSE project.

Zhebin Yu, Sara Kress, Natalia Blay, Petr Gregor, Hanna-Maria Kukk, Miriam Leskien, Renata Majewska, Max J Oosterwegel, Daniel Szabó, Margreet Ten Have and 38 more

Abstract read
In one paragraph

Article in The Lancet regional health. Europe, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

48 authors.

Zhebin YuInstitute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Sara KressIUF - Leibniz Research Institute for Environmental Medicine, Düsseldorf, Germany.
Natalia BlayGenomes for Life-GCAT Lab, CORE Program, Germans Trias I Pujol Research Institute (IGTP), Badalona, Spain.
Petr GregorRECETOX, Faculty of Science, Masaryk University, Brno, Czech Republic.
Hanna-Maria KukkInstitute of Genomics, University of Tartu, Estonia.
Miriam LeskienInstitute of Epidemiology, Helmholtz Zentrum München - German Research Center for Environmental Health, Neuherberg, Germany.
Renata MajewskaChair of Epidemiology and Preventive Medicine, Jagiellonian University Medical College, Kraków, Poland.
Max J OosterwegelInstitute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands.
Daniel SzabóRECETOX, Faculty of Science, Masaryk University, Brno, Czech Republic.
Margreet Ten HaveNetherlands Institute of Mental Health and Addiction, Utrecht, the Netherlands.
Jana KlánováRECETOX, Faculty of Science, Masaryk University, Brno, Czech Republic.
Ondřej MikešRECETOX, Faculty of Science, Masaryk University, Brno, Czech Republic.
Anna BergströmInstitute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Alonso BussalleuSwiss Tropical and Public Health Institute, Allschwil, Switzerland.
Rafael de CidGenomes for Life-GCAT Lab, CORE Program, Germans Trias I Pujol Research Institute (IGTP), Badalona, Spain.
Andrea DaleckaRECETOX, Faculty of Science, Masaryk University, Brno, Czech Republic.
Payam DadvandISGlobal, Barcelona, Spain.
Saskia van DorsselaerNetherlands Institute of Mental Health and Addiction, Utrecht, the Netherlands.
Krista FischerInstitute of Genomics, University of Tartu, Estonia.
Kees de HooghSwiss Tropical and Public Health Institute, Allschwil, Switzerland.
Gerard H KoppelmanUniversity of Groningen, University Medical Center Groningen, Beatrix Children's Hospital, Department of Pediatric Pulmonology and Pediatric Allergology, Groningen, the Netherlands.
Jaanika KronbergInstitute of Genomics, University of Tartu, Estonia.
Estonian Biobank Research Team
Jeroen LakerveldDepartment of Epidemiology and Data Science, Amsterdam UMC, Location Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
Petter LjungmanInstitute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Simon Kebede MeridDepartment of Clinical Sciences and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.
Pawel MacekCollegium Medicum, Jan Kochanowski University of Kielce, Poland.
Marta ManczukDepartment of Cancer Epidemiology and Primary Prevention, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Anne-Sophie MerrittInstitute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Agnieszka PacChair of Epidemiology and Preventive Medicine, Jagiellonian University Medical College, Kraków, Poland.
Priit PaltaInstitute of Genomics, University of Tartu, Estonia.
Göran PershagenInstitute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Annette PetersInstitute of Epidemiology, Helmholtz Zentrum München - German Research Center for Environmental Health, Neuherberg, Germany.
Hynek PikhartRECETOX, Faculty of Science, Masaryk University, Brno, Czech Republic.
Apolline SaucyInstitute of Social and Preventive Medicine (ISPM), University of Berne, Berne, Switzerland.
Tamara SchikowskiIUF - Leibniz Research Institute for Environmental Medicine, Düsseldorf, Germany.
Youchen ShenInstitute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands.
Marie StandlInstitute of Epidemiology, Helmholtz Zentrum München - German Research Center for Environmental Health, Neuherberg, Germany.
Cathryn TonneISGlobal, Barcelona, Spain.
Roel VermeulenInstitute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands.
Jelle VlaanderenInstitute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands.
Judith M VonkUniversity of Groningen, University Medical Center Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, the Netherlands.
Kathrin WolfInstitute of Epidemiology, Helmholtz Zentrum München - German Research Center for Environmental Health, Neuherberg, Germany.
Carl Henrik EkDepartment of Computer Science and Technology, University of Cambridge, Cambridge, Cambridgeshire, United Kingdom.
Olena GruzievaInstitute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
Ulrike GehringInstitute for Risk Assessment Sciences, Utrecht University, Utrecht, the Netherlands.
Erik MelénDepartment of Clinical Sciences and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.
EXPANSE project

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The joint impact of exposure to multiple urban environmental factors on asthma remains unclear. Methods: We analysed data from 14 European cohorts to assess the impact of the urban exposome on asthma incidence across the life course. We linked three external exposome domains (air pollution, built environment, ambient temperature) to the participants' home addresses at baseline. We performed k-means clustering within each domain and assessed associations of clusters with asthma adjusting for potentially relevant covariates in cohort-specific analyses, with subsequent separate meta-analyses for birth and adult cohorts. An environmental risk score using a coefficient-weighted sum approach was used to assess the impact of combining the three domains. Findings: A total of 7428 incident asthma cases were identified among 349,037 participants (from birth up to age 70+). Overall, we observed higher risks of asthma for clusters characterized by high particulate matter and nitrogen dioxide exposure in adults (OR Interpretation: Multiple environmental exposures jointly contribute to incident asthma risk across the life course. Urban planning accounting for these factors may help mitigate asthma development. Funding: This study was funded by the European Union's Horizon 2020 research and innovation program under agreement No 874627 (EXPANSE).

Indexed as

AsthmaCohortExposomeLife course

Identifiers

PMID40672052
PMCPMC12266180

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.